4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-24-040642
President, CEO acquired 6,725 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gilad Oren President, CEO | 2024-03-28 | Grant or award | +6,725 | 331,495 | D | ||
| Derivatives | |||||||
| Gilad Oren President, CEO | 2024-03-28 | Grant or award · Stock Options (Right to Buy) | +26,900 | 26,900 | D | ||
Loading xslF345X05/tm2410009-1_4seq1.xml…